Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazuyo Sasaki
Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients With Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan
Advances in Therapy
Medicine
Pharmacology
Related publications
Safety and Effectiveness of Istradefylline in Patients With Parkinson’s Disease: Interim Analysis of a Post-Marketing Surveillance Study in Japan
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Impact of Body Mass Index on the Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus: A Subgroup Analysis of 3‐month Interim Results From the STELLA ‐ LONG TERM Study
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Real-World Evidence for the Safety of Ipragliflozin in Elderly Japanese Patients With Type 2 Diabetes Mellitus (STELLA-ELDER): Final Results of a Post-Marketing Surveillance Study
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Efficacy and Safety of Imarikiren in Patients With Type 2 Diabetes and Microalbuminuria
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
Advances in Therapy
Medicine
Pharmacology
Exploratory Analysis of Comparative Clinical Trials Used for Marketing Approval in Patients With Type 2 Diabetes in Japan
SAGE Open Medicine
Medicine
Comparison of Teneligliptin and Atorvastatin on Lipid Profile in Patients With Type 2 Diabetes Mellitus
Current Research in Diabetes & Obesity Journal
Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment With a Prospective Post-Marketing Surveillance Study
Drugs - Real World Outcomes
Pharmacology
